These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 36563642)

  • 21. Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting.
    Jiao L; Tao Y; Ding H; Wu F; Liu Y; Li C; Li F
    3 Biotech; 2024 Sep; 14(9):215. PubMed ID: 39220827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
    Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
    BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.
    Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H
    J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma.
    Jiang W; Wei Q; Xie H; Wu D; He H; Lv X
    Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma.
    Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C
    Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Aizemaiti R; Wu Z; Tang J; Yan H; Lv X
    Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma.
    Hu Y; Liu Y; Ma C; Ai K
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FANCA promotes lung adenocarcinoma progression and is a potential target for epitope vaccine immunotherapy.
    Kang Y; Zhong R; Gan Y; You J; Chen J; Chen F; Chen L
    J Transl Med; 2024 Oct; 22(1):911. PubMed ID: 39375712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
    Song W; Wu X; Wang S; Barr MP; Rodríguez M; Oh IJ; Wu Y; Li D
    Transl Lung Cancer Res; 2023 Dec; 12(12):2476-2493. PubMed ID: 38205213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
    Wang N; Zhu L; Xu X; Yu C; Huang X
    Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer.
    Yin L; Shi J; Zhang J; Lin X; Jiang W; Zhu Y; Song Y; Lu Y; Ma Y
    Sci Rep; 2023 Dec; 13(1):22243. PubMed ID: 38097666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.
    Jin X; Chen L; Zhou N; Ni H; Zu L; He J; Yang L; Zhu Y; Sun X; Li X; Xu S
    Front Mol Biosci; 2021; 8():711928. PubMed ID: 34901148
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration.
    Zhou H; Li S; Lin Y
    PeerJ; 2023; 11():e15238. PubMed ID: 37187527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.